Goodsurance

Drug prices & Part D

About 140,000 Wellcare Part D Members Were Dropped Mid-Year After Small New Premiums Were Added to Their Previously Free Plans

KFF Health News found that Wellcare terminated tens of thousands of drug plan members in April 2026 when minimal monthly premiums went unpaid, leaving many without prescription coverage and at risk for permanent Medicare drug enrollment penalties.

By the Goodsurance editorial teamSeptember 21, 2026

KFF Health News reported in July 2026 that Wellcare Health Plans terminated approximately 140,000 members of its Value Script prescription drug plan in April 2026 after introducing a monthly premium to a plan that had been free for years. Many members did not pay the new charge, prompting mid-year disenrollment across 26 states and Washington, D.C.

The premium amounts involved were small. In Nevada, some members owed as little as 8 dollars and 10 cents for three months of accumulated unpaid charges. One beneficiary in the KFF Health News reporting saw his monthly premium rise from zero to 3 dollars and 60 cents.

Wellcare dropped about 140,000 Part D members mid-year after adding small new premiums to formerly free plans, leaving many at risk for permanent Medicare drug penalties, KFF Health News found.

Wellcare said roughly 40,000 of those terminated may qualify for the federal Extra Help program, also called the Low-Income Subsidy, which can allow immediate re-enrollment in a Part D plan. The remaining members generally cannot rejoin a drug plan until the fall annual enrollment period for 2027 coverage, absent a qualifying special enrollment event.

The financial stakes of a coverage gap are real. Under Medicare rules, people who go 63 or more consecutive days without creditable prescription drug coverage face a permanent monthly surcharge added to their future Part D premiums. The reporting illustrated the exposure: one beneficiary faced approximately 1,800 dollars for a 90-day supply of a blood thinner without Part D coverage.

KFF Health News also noted that the annual notice of changes disclosing the new premium ran 21 pages, raising questions about whether members had a realistic opportunity to notice and act before being dropped.

In plain words

A Medicare drug plan called Wellcare Value Script dropped about 140,000 members in April 2026. This happened in the middle of the year, not at the usual end-of-year enrollment period.

The plan had cost nothing for years. Then Wellcare added a small monthly fee. Many people did not know about it or did not pay. So Wellcare removed them. Some owed only a few dollars total.

This is serious. Under Medicare rules, if you go 63 days or more without drug coverage, you get a permanent penalty added to your future monthly premiums. And without a drug plan, medicines can cost a lot. One person in the news story had to pay about 1,800 dollars for a 90-day supply of a blood thinner.

About 40,000 of the dropped members may qualify for Extra Help, a program for lower-income people that can let them rejoin a plan right away. Others must wait for open enrollment this October.

The notice that explained the new premium was 21 pages long.

Source: KFF Health News
Read at the source →

More news

Other stories on what is moving in Medicare.

Drug prices & Part D

PhRMA Files Federal Lawsuit to Block Medicare's New International Drug Pricing Model

The pharmaceutical industry's main trade group sued the Trump administration on October 7, arguing that a new rule tying Medicare Part B drug payments to prices in other countries exceeds the government's legal authority.

October 7, 2026

Drug prices & Part D

Federal Watchdog: Medicare Drug Plans Tied to Pharmacy Chains Offer Lower Premiums but Substantially Higher Drug Costs

With open enrollment eight days away, a federal audit found that Part D plans run by companies that also own pharmacies and pharmacy benefit managers dominate the market, but their enrollees pay substantially more out of pocket when filling prescriptions.

October 7, 2026

Drug prices & Part D

Fifteen Medicare Part D Drugs Will Have Federally Negotiated Prices in 2027, Including Ozempic

With open enrollment opening October 15, every Part D and Medicare Advantage drug plan will be required to cover all 15 negotiated medicines at or below their maximum fair prices starting January 1.

October 6, 2026

Drug prices & Part D

Zero-Premium Part D Drug Plans Disappear in 2027, Leaving 4 Million Enrollees Without the Free Option They Had This Year

A KFF analysis published the day plan shopping opened finds no standalone Medicare drug plan will be offered at zero monthly cost to non-subsidized enrollees in 2027, and some face increases of 50 dollars or more per month if they do not switch.

October 2, 2026

Drug prices & Part D

Medicare Sent Its Final Drug Price Offers by September 30. Manufacturers Now Have Until October 31 to Respond.

With the statutory September 30 written-offer deadline now passed, each manufacturer whose drug is in Medicare's third negotiation cycle must accept or reject CMS's maximum fair price offer in writing by October 31, closing the formal negotiation period.

October 1, 2026

Drug prices & Part D

CMS Finalizes Mandatory Model to Tie Medicare Part B Drug Prices to International Benchmarks

A five-year payment test launching January 1, 2027, will require drug manufacturers to pay rebates when what they charge Medicare exceeds prices paid in 19 other countries, affecting about one quarter of Original Medicare enrollees.

October 1, 2026